Viewing Study NCT01160094


Ignite Creation Date: 2025-12-25 @ 1:44 AM
Ignite Modification Date: 2026-01-06 @ 2:56 PM
Study NCT ID: NCT01160094
Status: COMPLETED
Last Update Posted: 2016-03-28
First Post: 2010-07-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Role of Early Versus Late Switch to Lapatinib-Capecitabine (TYCO)
Sponsor: Novartis
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Trastuzumab View
None Metastatic Breast Cancer View
None Breast Cancer View
None Observational Study View
None Lapatinib View